HighPoint Advisor Group LLC - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 11 filers reported holding KAZIA THERAPEUTICS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighPoint Advisor Group LLC ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q4 2020$368,000
+60.0%
32,435
-15.6%
0.04%
+7.1%
Q3 2020$230,000
+113.0%
38,435
+18.5%
0.04%
+82.6%
Q2 2020$108,000
+17.4%
32,4350.0%0.02%
+4.5%
Q1 2020$92,000
-35.2%
32,4350.0%0.02%
-24.1%
Q4 2019$142,000
+47.9%
32,4350.0%0.03%
+38.1%
Q3 2019$96,00032,4350.02%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q2 2020
NameSharesValueWeighting ↓
UBS Group AG 960$5,0000.00%
AdvisorNet Financial, Inc 5$00.00%
BREWIN DOLPHIN LTD 32$1800.00%
MORGAN STANLEY 50,001$281,0000.00%
ACADIAN ASSET MANAGEMENT LLC 8,101$45,0000.00%
Renaissance Technologies 34,325$193,0000.00%
ROYAL BANK OF CANADA 1,250$7,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders